• Japanese
  • Korean
  • Chinese
Cover Image

Thromboembolism Global Clinical Trials Review, H2, 2013

GlobalData's clinical trial report, "Thromboembolism Global Clinical Trials Review, H2, 2013" provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Introduction 6
  • Thromboembolism 6
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by BRIC Nations 15
  • Clinical Trials by G7 Nations 16
  • Clinical Trials in G7 Nations by Trial Status 17
  • Clinical Trials by E7 Nations 18
  • Clinical Trials in E7 Nations by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Unaccomplished Trials of Thromboembolism 23
  • Subjects Recruited Over a Period of Time 28
  • Prominent Sponsors 29
  • Top Companies Participating in Thromboembolism Therapeutics Clinical Trials 30
  • Prominent Drug Comparison 32
  • Clinical Trial Profiles 33
  • Clinical Trial Overview of Top Companies 33
  • Bayer AG 33
  • Clinical Trial Overview of Bayer AG 33
  • Sanofi 36
  • Clinical Trial Overview of Sanofi 36
  • C. H. Boehringer Sohn AG & Co. KG 38
  • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 38
  • GlaxoSmithKline plc 40
  • Clinical Trial Overview of GlaxoSmithKline plc 40
  • Astellas Pharma Inc. 42
  • Clinical Trial Overview of Astellas Pharma Inc. 42
  • Pfizer Inc. 44
  • Clinical Trial Overview of Pfizer Inc. 44
  • Daiichi Sankyo Company, Limited 46
  • Clinical Trial Overview of Daiichi Sankyo Company, Limited 46
  • AstraZeneca PLC 48
  • Clinical Trial Overview of AstraZeneca PLC 48
  • Bristol-Myers Squibb Company 50
  • Clinical Trial Overview of Bristol-Myers Squibb Company 50
  • The LEO Foundation 51
  • Clinical Trial Overview of The LEO Foundation 51
  • Clinical Trial Overview of Top Institutes / Government 52
  • National Heart, Lung, and Blood Institute 52
  • Clinical Trial Overview of National Heart, Lung, and Blood Institute 52
  • Ottawa Hospital Research Institute 53
  • Clinical Trial Overview of Ottawa Hospital Research Institute 53
  • Hamilton Health Sciences 54
  • Clinical Trial Overview of Hamilton Health Sciences 54
  • Beijing Chao Yang Hospital 55
  • Clinical Trial Overview of Beijing Chao Yang Hospital 55
  • University of Zurich 56
  • Clinical Trial Overview of University of Zurich 56
  • Brigham and Women's Hospital 57
  • Clinical Trial Overview of Brigham and Women's Hospital 57
  • Capital District Health Authority, Canada 58
  • Clinical Trial Overview of Capital District Health Authority, Canada 58
  • McMaster University 59
  • Clinical Trial Overview of McMaster University 59
  • Centre Hospitalier Universitaire de Saint Etienne 60
  • Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 60
  • Universita di Padova 61
  • Clinical Trial Overview of Universita di Padova 61
  • Five Key Clinical Profiles 62

Appendix 172

  • Abbreviations 172
  • Definitions 172
  • Research Methodology 173
  • Secondary Research 173
  • About GlobalData 174
  • Contact Us 174
  • Disclaimer 174
  • Source 175

List of Tables

  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
  • Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
  • Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
  • Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
  • Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
  • Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13
  • Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
  • Thromboembolism Therapeutics Clinical Trials, BRIC Countries, 2013* 15
  • Thromboembolism Therapeutics Clinical Trials, G7 Countries, 2013* 16
  • Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
  • Thromboembolism Therapeutics Clinical Trials, E7 Countries, 2013* 18
  • Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
  • Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
  • Thromboembolism Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
  • Thromboembolism Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
  • Thromboembolism Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25
  • Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
  • Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
  • Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
  • Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 33
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 36
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2013* 38
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 40
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2013* 42
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 44
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 46
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 48
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 50
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The LEO Foundation, 2013* 51
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 52
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2013* 53
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2013* 54
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Chao Yang Hospital, 2013* 55
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013* 56
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2013* 57
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2013* 58
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2013* 59
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2013* 60
  • Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita di Padova, 2013* 61

List of Figures

  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
  • Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
  • Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
  • Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
  • Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
  • Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13
  • Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
  • Thromboembolism Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
  • Thromboembolism Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
  • Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
  • Thromboembolism Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
  • Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
  • Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
  • Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
  • Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
  • Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
  • Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
  • Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
  • GlobalData Methodology 173
Show More
Pricing